| MODIGRAF ASTELLAS PHARMA INC.
1457201 29 Oct 2009 | on 22 May 2013 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances, namely, immunotherapeutics designed to reduce the activity of the patients immune system and so the risk of organ rejection after allogenic organ transplants or bone marrow transplants, and for the treatment of severe atopic dermatitis and autoimmune diseases namely, rheumatoid arthritis | | | MODIGRAF DESIGN ASTELLAS PHARMA INC.
1302844 25 May 2006 | on 17 Jun 2009 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances, namely, immunotherapeutics designed to reduce the activity of the patient's immune system and so the risk of organ rejection after allogenic organ transplants or bone marrow transplants, and for the treatment of severe atopic dermatitis and autoimmune diseases such as rheumatoid arthritis. | | 
